Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
28.9M
Number of holders
19
Total 13F shares, excl. options
1.38M
Shares change
-84.3K
Total reported value, excl. options
$2.74M
Value change
-$208K
Number of buys
11
Number of sells
-6
Price
$1.98

Significant Holders of MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) as of Q4 2024

23 filings reported holding MAIA - MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
MAIA Biotechnology, Inc. - Common Stock, par value $0.0001 per share (MAIA) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1.38M shares of 28.9M outstanding shares and own 4.78% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (583K shares), Halter Ferguson Financial Inc. (241K shares), GEODE CAPITAL MANAGEMENT, LLC (198K shares), BlackRock, Inc. (84.8K shares), Centric Wealth Management (68.2K shares), STATE STREET CORP (53.3K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (45.7K shares), JANE STREET GROUP, LLC (39.1K shares), NORTHERN TRUST CORP (32.1K shares), and WEALTH ENHANCEMENT ADVISORY SERVICES, LLC (14.8K shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.